Search research articles
Contact Us
Filters
Showing results (181-190 of 197) with videos related to
Page
of 20
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2014
Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma
Carsten Kobe, Georg Kuhnert, Deniz Kahraman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2011
[18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma
Sandra Purz, Christine Mauz-Körholz, Dieter Körholz, et al.
Blood
|
September 2, 2008
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma
Carsten Kobe, Markus Dietlein, Jeremy Franklin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2022
Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma
Marco Lodrini, Josefine Graef, Theresa M Thole-Kliesch, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 2, 2022
Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib
Osman Öcal, Kerstin Schütte, Christoph J Zech, et al.
Ebiomedicine
|
May 21, 2025
Combined [<sup>18</sup>F]Fluorodeoxyglucose PET and [<sup>123</sup>I]Iodometomidate-SPECT for diagnostic evaluation of indeterminate adrenal neoplasias-the cross-sectional diagnostic test accuracy study FAMIAN
Stefanie Hahner, Philipp Hartrampf, Felix Beuschlein, et al.
The Journal of Clinical Investigation
|
July 20, 2018
JAK2-V617F promotes venous thrombosis through β1/β2 integrin activation
Bärbel Edelmann, Nibedita Gupta, Tina M Schnoeder, et al.
United European Gastroenterology Journal
|
July 15, 2024
Skeletal muscle quality predicts overall survival in advanced liver hepatocellular carcinoma treated with SIRT and sorafenib: A subanalysis of the SORAMIC trial
Alexey Surov, Andreas Wienke, Jan Borggrefe, et al.
Digestive Diseases (Basel, Switzerland)
|
April 29, 2026
Bone mineral density does not predict overall survival in patients with advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial
Maximilian Thormann, Andreas Wienke, Ricarda Seidensticker, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
August 18, 2023
Prognostic role of radiomics-based body composition analysis for the 1-year survival for hepatocellular carcinoma patients
Sylvia Saalfeld, Robert Kreher, Georg Hille, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 197) with videos related to
Sort By:
Page
of 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2014
Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma
Carsten Kobe, Georg Kuhnert, Deniz Kahraman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2011
[18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma
Sandra Purz, Christine Mauz-Körholz, Dieter Körholz, et al.
Blood
|
September 2, 2008
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma
Carsten Kobe, Markus Dietlein, Jeremy Franklin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2022
Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma
Marco Lodrini, Josefine Graef, Theresa M Thole-Kliesch, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 2, 2022
Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib
Osman Öcal, Kerstin Schütte, Christoph J Zech, et al.
Ebiomedicine
|
May 21, 2025
Combined [<sup>18</sup>F]Fluorodeoxyglucose PET and [<sup>123</sup>I]Iodometomidate-SPECT for diagnostic evaluation of indeterminate adrenal neoplasias-the cross-sectional diagnostic test accuracy study FAMIAN
Stefanie Hahner, Philipp Hartrampf, Felix Beuschlein, et al.
The Journal of Clinical Investigation
|
July 20, 2018
JAK2-V617F promotes venous thrombosis through β1/β2 integrin activation
Bärbel Edelmann, Nibedita Gupta, Tina M Schnoeder, et al.
United European Gastroenterology Journal
|
July 15, 2024
Skeletal muscle quality predicts overall survival in advanced liver hepatocellular carcinoma treated with SIRT and sorafenib: A subanalysis of the SORAMIC trial
Alexey Surov, Andreas Wienke, Jan Borggrefe, et al.
Digestive Diseases (Basel, Switzerland)
|
April 29, 2026
Bone mineral density does not predict overall survival in patients with advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial
Maximilian Thormann, Andreas Wienke, Ricarda Seidensticker, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
August 18, 2023
Prognostic role of radiomics-based body composition analysis for the 1-year survival for hepatocellular carcinoma patients
Sylvia Saalfeld, Robert Kreher, Georg Hille, et al.
Page
of 20